Detalhe da pesquisa
1.
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience.
Front Oncol
; 12: 795955, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392224